New Study Examines Relationship Between Vitamin D Levels and Bone Density in People with Lupus
Researchers discovered an association between hypovitaminosis D (also known as vitamin D deficiency) and high inflammatory activity, severe organ damage, culminative dosage of glucocorticoids, bone turnover marker (BTM) changes, and bone mineral density (BMD) decline in people with lupus. Vitamin D deficiency is a disorder caused by a shortage of vitamin D in the body from either inadequate dietary intake or health conditions that prevent the body from properly absorbing vitamin D. Vitamin D deficiency is common in people with lupus. Previous studies have shown that vitamin D insufficiency occurs in two-thirds of people with lupus and deficiency occurs in 20% of people with the disease.
The researchers looked at vitamin D levels and BMD in 101 people (90 women and 11 men) with lupus. 29 of the 101 people were placed in the study control group. Study participants were tested on a number of factors, including vitamin D levels and C reactive protein (a standard biomarker for inflammation) among others. Researchers found that among the participants:
- 62.3% had vitamin D deficiency, 29.7% exhibited vitamin D insufficiency, and only 7.93% had normal levels of vitamin D.
- Women had significantly lower vitamin D levels than men by more than 25%.
- Vitamin D status was not associated with age or disease course.
Vitamin D is later developed into the hormone calcitriol which is important to regulating calcium in the body and for bone metabolism. Vitamin D is also important in the human immune response. Further research is needed to understand the role of Vitamin D in lupus disease, specifically the relationship between BTM and BTD and inflammation. Learn more about lupus and bone health.
Interested in getting research like this straight to your inbox? Subscribe to our bimonthly Inside Lupus Research email for all the latest.Subscribe Now